Skip to content

PP&E (Net) at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
$100.93M+82.1%
Guardant Health logo
Guardant HealthGH
$150.04M+16.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$24.19M-10.3%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$116.34M+8.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$48.44M+0.9%
GeneDx Holdings logo
GeneDx HoldingsWGS
$50.13M+37.8%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's PP&E (net)?
Lucid Diagnostics (LUCD) reported PP&E (net) of $907K in Q1 2026.
How has Lucid Diagnostics's PP&E (net) changed year-over-year?
Lucid Diagnostics's PP&E (net) decreased by 12.8% year-over-year, from $1.04M to $907K.
What is the long-term trend for Lucid Diagnostics's PP&E (net)?
Over 4 years (2021 to 2025), Lucid Diagnostics's PP&E (net) has grown at a -4.5% compound annual growth rate (CAGR), from $971K to $809K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.